Table 1. Correlations between miR-31 and E2F2 expressions and clinical characteristics in patients with gastric cancer.
Characteristics | Total No. | miR-31 expression | E2F2 expression | ||||
---|---|---|---|---|---|---|---|
Low | High | P-value | Low | High | P-value | ||
No. case (%) | No. case (%) | No. case (%) | No. case (%) | ||||
Age | 0.055 | 0.623 | |||||
< 60 | 18 | 6 (30) | 12 (60) | 5 (45) | 13 (45) | ||
≥ 60 | 22 | 14 (70) | 8 (40) | 6 (55) | 16 (55) | ||
Gender | 0.095 | 0.157 | |||||
Male | 25 | 15 (75) | 10 (50) | 5 (45) | 20 (69) | ||
Female | 15 | 5 (25) | 10 (50) | 6 (55) | 9 (31) | ||
Tumor size | 0.264 | 0.422 | |||||
< 5 cm | 19 | 11 (55) | 8 (40) | 6 (55) | 13 (45) | ||
≥ 5 cm | 21 | 9 (45) | 12 (60) | 5 (45) | 16 (55) | ||
Differentiation status | |||||||
Moderate | 18 | 5 (25) | 13 (65) | 0.012* | 9 (82) | 9 (31) | 0.005* |
Poor | 22 | 15 (75) | 7 (35) | 2 (18) | 20 (69) | ||
Lymph node invasion | 0.000* | 0.008* | |||||
N0 | 4 | 0 (0) | 4 (20) | 4 (36) | 0 (0) | ||
N1 | 10 | 0 (0) | 10 (50) | 5 (45) | 5 (17) | ||
N2 | 9 | 5 (25) | 4 (20) | 1 (9) | 8 (28) | ||
N3 | 17 | 15 (75) | 2 (10) | 1 (9) | 16 (55) | ||
T stage | 0.005* | 0.030* | |||||
T1 | 2 | 0 (0) | 2 (10) | 2 (18) | 0 (0) | ||
T2 | 4 | 0 (0) | 4 (20) | 2 (18) | 2 (7) | ||
T3 | 27 | 13 (65) | 14 (70) | 7 (64) | 20 (69) | ||
T4 | 7 | 7 (35) | 0 (0) | 0 (0) | 7 (24) | ||
Distant metastasis | 0.366 | 0.275 | |||||
M0 | 28 | 13 (65) | 15 (75) | 9 (82) | 19 (66) | ||
M1 | 12 | 7 (35) | 5 (25) | 2 (18) | 10 (34) |